Global Vancomycin Market Growth 2020-2025

Global Vancomycin Market Growth 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vancomycin Consumption 2015-2025
2.1.2 Vancomycin Consumption CAGR by Region
2.2 Vancomycin Segment by Type
2.2.1 Daptomycin
2.2.2 Linezolid
2.2.3 Quinupristin
2.2.4 Ampicillin
2.2.5 Chloramphenicol
2.2.6 Others
2.3 Vancomycin Consumption by Type
2.3.1 Global Vancomycin Consumption Market Share by Type (2015-2020)
2.3.2 Global Vancomycin Revenue and Market Share by Type (2015-2020)
2.3.3 Global Vancomycin Sale Price by Type (2015-2020)
2.4 Vancomycin Segment by Application
2.4.1 Sepsis
2.4.2 Lung Infection
2.4.3 Skin Soft Tissue Infection
2.4.4 Colitis & Intestinal Inflammation
2.4.5 To Prevent Infection
2.5 Vancomycin Consumption by Application
2.5.1 Global Vancomycin Consumption Market Share by Type (2015-2020)
2.5.2 Global Vancomycin Value and Market Share by Type (2015-2020)
2.5.3 Global Vancomycin Sale Price by Type (2015-2020)

3 Global Vancomycin by Company
3.1 Global Vancomycin Sales Market Share by Company
3.1.1 Global Vancomycin Sales by Company (2018-2020)
3.1.2 Global Vancomycin Sales Market Share by Company (2018-2020)
3.2 Global Vancomycin Revenue Market Share by Company
3.2.1 Global Vancomycin Revenue by Company (2018-2020)
3.2.2 Global Vancomycin Revenue Market Share by Company (2018-2020)
3.3 Global Vancomycin Sale Price by Company
3.4 Global Vancomycin Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Vancomycin Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Vancomycin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Vancomycin by Regions
4.1 Vancomycin by Regions
4.2 Americas Vancomycin Consumption Growth
4.3 APAC Vancomycin Consumption Growth
4.4 Europe Vancomycin Consumption Growth
4.5 Middle East & Africa Vancomycin Consumption Growth

5 Americas
5.1 Americas Vancomycin Consumption by Countries
5.1.1 Americas Vancomycin Consumption by Countries (2015-2020)
5.1.2 Americas Vancomycin Value by Countries (2015-2020)
5.2 Americas Vancomycin Consumption by Type
5.3 Americas Vancomycin Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Vancomycin Consumption by Regions
6.1.1 APAC Vancomycin Consumption by Regions (2015-2020)
6.1.2 APAC Vancomycin Value by Regions (2015-2020)
6.2 APAC Vancomycin Consumption by Type
6.3 APAC Vancomycin Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Vancomycin by Countries
7.1.1 Europe Vancomycin Consumption by Countries (2015-2020)
7.1.2 Europe Vancomycin Value by Countries (2015-2020)
7.2 Europe Vancomycin Consumption by Type
7.3 Europe Vancomycin Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Vancomycin by Countries
8.1.1 Middle East & Africa Vancomycin Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Vancomycin Value by Countries (2015-2020)
8.2 Middle East & Africa Vancomycin Consumption by Type
8.3 Middle East & Africa Vancomycin Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Vancomycin Distributors
10.3 Vancomycin Customer

11 Global Vancomycin Market Forecast
11.1 Global Vancomycin Consumption Forecast (2021-2025)
11.2 Global Vancomycin Forecast by Regions
11.2.1 Global Vancomycin Forecast by Regions (2021-2025)
11.2.2 Global Vancomycin Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Vancomycin Forecast by Type
11.8 Global Vancomycin Forecast by Application

12 Key Players Analysis
12.1 Pfizer
12.1.1 Company Information
12.1.2 Vancomycin Product Offered
12.1.3 Pfizer Vancomycin Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Pfizer Latest Developments
12.2 Enanta Pharmaceuticals
12.2.1 Company Information
12.2.2 Vancomycin Product Offered
12.2.3 Enanta Pharmaceuticals Vancomycin Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Enanta Pharmaceuticals Latest Developments
12.3 Eli Lilly and Company
12.3.1 Company Information
12.3.2 Vancomycin Product Offered
12.3.3 Eli Lilly and Company Vancomycin Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Eli Lilly and Company Latest Developments
12.4 Xellia Pharmaceuticals ApS
12.4.1 Company Information
12.4.2 Vancomycin Product Offered
12.4.3 Xellia Pharmaceuticals ApS Vancomycin Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Xellia Pharmaceuticals ApS Latest Developments
12.5 VIANEX
12.5.1 Company Information
12.5.2 Vancomycin Product Offered
12.5.3 VIANEX Vancomycin Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 VIANEX Latest Developments
12.6 CJ CheilJedang
12.6.1 Company Information
12.6.2 Vancomycin Product Offered
12.6.3 CJ CheilJedang Vancomycin Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 CJ CheilJedang Latest Developments
12.7 Aphios Corporation
12.7.1 Company Information
12.7.2 Vancomycin Product Offered
12.7.3 Aphios Corporation Vancomycin Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Aphios Corporation Latest Developments
12.8 Alchemia Limited
12.8.1 Company Information
12.8.2 Vancomycin Product Offered
12.8.3 Alchemia Limited Vancomycin Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Alchemia Limited Latest Developments
12.9 Cellceutix Corporation
12.9.1 Company Information
12.9.2 Vancomycin Product Offered
12.9.3 Cellceutix Corporation Vancomycin Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Cellceutix Corporation Latest Developments
12.10 Alvogen
12.10.1 Company Information
12.10.2 Vancomycin Product Offered
12.10.3 Alvogen Vancomycin Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Alvogen Latest Developments
12.11 MicuRx Pharmaceuticals
12.11.1 Company Information
12.11.2 Vancomycin Product Offered
12.11.3 MicuRx Pharmaceuticals Vancomycin Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 MicuRx Pharmaceuticals Latest Developments
12.12 NovaBay Pharmaceuticals
12.12.1 Company Information
12.12.2 Vancomycin Product Offered
12.12.3 NovaBay Pharmaceuticals Vancomycin Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 NovaBay Pharmaceuticals Latest Developments
12.13 Nabriva Therapeutics
12.13.1 Company Information
12.13.2 Vancomycin Product Offered
12.13.3 Nabriva Therapeutics Vancomycin Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Nabriva Therapeutics Latest Developments
12.14 Helix BioMedix
12.14.1 Company Information
12.14.2 Vancomycin Product Offered
12.14.3 Helix BioMedix Vancomycin Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Helix BioMedix Latest Developments
12.15 MGB Biopharma Limited
12.15.1 Company Information
12.15.2 Vancomycin Product Offered
12.15.3 MGB Biopharma Limited Vancomycin Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 MGB Biopharma Limited Latest Developments
12.16 Lytix Biopharma
12.16.1 Company Information
12.16.2 Vancomycin Product Offered
12.16.3 Lytix Biopharma Vancomycin Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Lytix Biopharma Latest Developments
12.17 Oragenics
12.17.1 Company Information
12.17.2 Vancomycin Product Offered
12.17.3 Oragenics Vancomycin Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Oragenics Latest Developments
12.18 Microbiotix.
12.18.1 Company Information
12.18.2 Vancomycin Product Offered
12.18.3 Microbiotix. Vancomycin Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 Microbiotix. Latest Developments
12.19 LegoChem Biosciences
12.19.1 Company Information
12.19.2 Vancomycin Product Offered
12.19.3 LegoChem Biosciences Vancomycin Sales, Revenue, Price and Gross Margin (2018-2020)
12.19.4 Main Business Overview
12.19.5 LegoChem Biosciences Latest Developments
12.20 NovoBiotic Pharmaceuticals
12.20.1 Company Information
12.20.2 Vancomycin Product Offered
12.20.3 NovoBiotic Pharmaceuticals Vancomycin Sales, Revenue, Price and Gross Margin (2018-2020)
12.20.4 Main Business Overview
12.20.5 NovoBiotic Pharmaceuticals Latest Developments
12.21 Shenwei Pharmaceutical
12.21.1 Company Information
12.21.2 Vancomycin Product Offered
12.21.3 Shenwei Pharmaceutical Vancomycin Sales, Revenue, Price and Gross Margin (2018-2020)
12.21.4 Main Business Overview
12.21.5 Shenwei Pharmaceutical Latest Developments
12.22 North China Pharmaceutical
12.22.1 Company Information
12.22.2 Vancomycin Product Offered
12.22.3 North China Pharmaceutical Vancomycin Sales, Revenue, Price and Gross Margin (2018-2020)
12.22.4 Main Business Overview
12.22.5 North China Pharmaceutical Latest Developments
12.23 Taiwan Zhengde Pharmaceutical
12.23.1 Company Information
12.23.2 Vancomycin Product Offered
12.23.3 Taiwan Zhengde Pharmaceutical Vancomycin Sales, Revenue, Price and Gross Margin (2018-2020)
12.23.4 Main Business Overview
12.23.5 Taiwan Zhengde Pharmaceutical Latest Developments
12.24 Zhejiang Pharmaceutical
12.24.1 Company Information
12.24.2 Vancomycin Product Offered
12.24.3 Zhejiang Pharmaceutical Vancomycin Sales, Revenue, Price and Gross Margin (2018-2020)
12.24.4 Main Business Overview
12.24.5 Zhejiang Pharmaceutical Latest Developments
12.25 Sealife Pharma
12.25.1 Company Information
12.25.2 Vancomycin Product Offered
12.25.3 Sealife Pharma Vancomycin Sales, Revenue, Price and Gross Margin (2018-2020)
12.25.4 Main Business Overview
12.25.5 Sealife Pharma Latest Developments
12.26 Zhejiang Haizheng Pharmaceutical
12.26.1 Company Information
12.26.2 Vancomycin Product Offered
12.26.3 Zhejiang Haizheng Pharmaceutical Vancomycin Sales, Revenue, Price and Gross Margin (2018-2020)
12.26.4 Main Business Overview
12.26.5 Zhejiang Haizheng Pharmaceutical Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Vancomycin Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Daptomycin
Table 5. Major Players of Linezolid
Table 6. Major Players of Quinupristin
Table 7. Major Players of Ampicillin
Table 8. Major Players of Chloramphenicol
Table 9. Major Players of Others
Table 10. Global Consumption Sales by Type (2015-2020)
Table 11. Global Vancomycin Consumption Market Share by Type (2015-2020)
Table 12. Global Vancomycin Revenue by Type (2015-2020) ($ million)
Table 13. Global Vancomycin Value Market Share by Type (2015-2020) ($ Millions)
Table 14. Global Vancomycin Sale Price by Type (2015-2020)
Table 15. Global Consumption Sales by Application (2015-2020)
Table 16. Global Vancomycin Consumption Market Share by Application (2015-2020)
Table 17. Global Vancomycin Value by Application (2015-2020)
Table 18. Global Vancomycin Value Market Share by Application (2015-2020)
Table 19. Global Vancomycin Sale Price by Application (2015-2020)
Table 20. Global Vancomycin Sales by Company (2017-2019) (KG)
Table 21. Global Vancomycin Sales Market Share by Company (2017-2019)
Table 22. Global Vancomycin Revenue by Company (2017-2019) ($ Millions)
Table 23. Global Vancomycin Revenue Market Share by Company (2017-2019)
Table 24. Global Vancomycin Sale Price by Company (2017-2019)
Table 25. Global Vancomycin Manufacturing Base Distribution and Sales Area by Manufacturers
Table 26. Players Vancomycin Products Offered
Table 27. Vancomycin Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 28. Global Vancomycin Consumption by Regions 2015-2020 (KG)
Table 29. Global Vancomycin Consumption Market Share by Regions 2015-2020
Table 30. Global Vancomycin Value by Regions 2015-2020 ($ Millions)
Table 31. Global Vancomycin Value Market Share by Regions 2015-2020
Table 32. Americas Vancomycin Consumption by Countries (2015-2020) (KG)
Table 33. Americas Vancomycin Consumption Market Share by Countries (2015-2020)
Table 34. Americas Vancomycin Value by Countries (2015-2020) ($ Millions)
Table 35. Americas Vancomycin Value Market Share by Countries (2015-2020)
Table 36. Americas Vancomycin Consumption by Type (2015-2020) (KG)
Table 37. Americas Vancomycin Consumption Market Share by Type (2015-2020)
Table 38. Americas Vancomycin Consumption by Application (2015-2020) (KG)
Table 39. Americas Vancomycin Consumption Market Share by Application (2015-2020)
Table 40. APAC Vancomycin Consumption by Countries (2015-2020) (KG)
Table 41. APAC Vancomycin Consumption Market Share by Countries (2015-2020)
Table 42. APAC Vancomycin Value by Regions (2015-2020) ($ Millions)
Table 43. APAC Vancomycin Value Market Share by Regions (2015-2020)
Table 44. APAC Vancomycin Consumption by Type (2015-2020) (KG)
Table 45. APAC Vancomycin Consumption Market Share by Type (2015-2020)
Table 46. APAC Vancomycin Consumption by Application (2015-2020) (KG)
Table 47. APAC Vancomycin Consumption Market Share by Application (2015-2020)
Table 48. Europe Vancomycin Consumption by Countries (2015-2020) (KG)
Table 49. Europe Vancomycin Consumption Market Share by Countries (2015-2020)
Table 50. Europe Vancomycin Value by Countries (2015-2020) ($ Millions)
Table 51. Europe Vancomycin Value Market Share by Countries (2015-2020)
Table 52. Europe Vancomycin Consumption by Type (2015-2020) (KG)
Table 53. Europe Vancomycin Consumption Market Share by Type (2015-2020)
Table 54. Europe Vancomycin Consumption by Application (2015-2020) (KG)
Table 55. Europe Vancomycin Consumption Market Share by Application (2015-2020)
Table 56. Middle East & Africa Vancomycin Consumption by Countries (2015-2020) (KG)
Table 57. Middle East & Africa Vancomycin Consumption Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Vancomycin Value by Countries (2015-2020) ($ Millions)
Table 59. Middle East & Africa Vancomycin Value Market Share by Countries (2015-2020)
Table 60. Middle East & Africa Vancomycin Consumption by Type (2015-2020) (KG)
Table 61. Middle East & Africa Vancomycin Consumption Market Share by Type (2015-2020)
Table 62. Middle East & Africa Vancomycin Consumption by Application (2015-2020) (KG)
Table 63. Middle East & Africa Vancomycin Consumption Market Share by Application (2015-2020)
Table 64. Vancomycin Distributors List
Table 65. Vancomycin Customer List
Table 66. Global Vancomycin Consumption Forecast by Countries (2021-2025) (KG)
Table 67. Global Vancomycin Consumption Market Forecast by Regions
Table 68. Global Vancomycin Value Forecast by Countries (2021-2025) ($ Millions)
Table 69. Global Vancomycin Value Market Share Forecast by Regions
Table 70. Global Vancomycin Consumption Forecast by Type (2021-2025) (KG)
Table 71. Global Vancomycin Consumption Market Share Forecast by Type (2021-2025)
Table 72. Global Vancomycin Value Forecast by Type (2021-2025) ($ Millions)
Table 73. Global Vancomycin Value Market Share Forecast by Type (2021-2025)
Table 74. Global Vancomycin Consumption Forecast by Application (2021-2025) (KG)
Table 75. Global Vancomycin Consumption Market Share Forecast by Application (2021-2025)
Table 76. Global Vancomycin Value Forecast by Application (2021-2025) ($ Millions)
Table 77. Global Vancomycin Value Market Share Forecast by Application (2021-2025)
Table 78. Pfizer Product Offered
Table 79. Pfizer Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 80. Pfizer Main Business
Table 81. Pfizer Latest Developments
Table 82. Pfizer Basic Information, Company Total Revenue (in $ million), Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 83. Enanta Pharmaceuticals Product Offered
Table 84. Enanta Pharmaceuticals Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 85. Enanta Pharmaceuticals Main Business
Table 86. Enanta Pharmaceuticals Latest Developments
Table 87. Enanta Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 88. Eli Lilly and Company Product Offered
Table 89. Eli Lilly and Company Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 90. Eli Lilly and Company Main Business
Table 91. Eli Lilly and Company Latest Developments
Table 92. Eli Lilly and Company Basic Information, Company Total Revenue (in $ million), Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 93. Xellia Pharmaceuticals ApS Product Offered
Table 94. Xellia Pharmaceuticals ApS Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 95. Xellia Pharmaceuticals ApS Main Business
Table 96. Xellia Pharmaceuticals ApS Latest Developments
Table 97. Xellia Pharmaceuticals ApS Basic Information, Company Total Revenue (in $ million), Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 98. VIANEX Product Offered
Table 99. VIANEX Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 100. VIANEX Main Business
Table 101. VIANEX Latest Developments
Table 102. VIANEX Basic Information, Company Total Revenue (in $ million), Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 103. CJ CheilJedang Product Offered
Table 104. CJ CheilJedang Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 105. CJ CheilJedang Main Business
Table 106. CJ CheilJedang Latest Developments
Table 107. CJ CheilJedang Basic Information, Company Total Revenue (in $ million), Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 108. Aphios Corporation Product Offered
Table 109. Aphios Corporation Basic Information, Company Total Revenue (in $ million), Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 110. Aphios Corporation Main Business
Table 111. Aphios Corporation Latest Developments
Table 112. Aphios Corporation Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 113. Alchemia Limited Product Offered
Table 114. Alchemia Limited Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 115. Alchemia Limited Main Business
Table 116. Alchemia Limited Latest Developments
Table 117. Alchemia Limited Basic Information, Company Total Revenue (in $ million), Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 118. Cellceutix Corporation Product Offered
Table 119. Cellceutix Corporation Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 120. Cellceutix Corporation Main Business
Table 121. Cellceutix Corporation Latest Developments
Table 122. Cellceutix Corporation Basic Information, Company Total Revenue (in $ million), Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 123. Alvogen Product Offered
Table 124. Alvogen Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 125. Alvogen Main Business
Table 126. Alvogen Latest Developments
Table 127. Alvogen Basic Information, Company Total Revenue (in $ million), Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 128. MicuRx Pharmaceuticals Product Offered
Table 129. MicuRx Pharmaceuticals Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 130. MicuRx Pharmaceuticals Main Business
Table 131. MicuRx Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 132. MicuRx Pharmaceuticals Latest Developments
Table 133. NovaBay Pharmaceuticals Product Offered
Table 134. NovaBay Pharmaceuticals Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 135. NovaBay Pharmaceuticals Main Business
Table 136. NovaBay Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 137. NovaBay Pharmaceuticals Latest Developments
Table 138. Nabriva Therapeutics Product Offered
Table 139. Nabriva Therapeutics Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 140. Nabriva Therapeutics Main Business
Table 141. Nabriva Therapeutics Latest Developments
Table 142. Nabriva Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 143. Helix BioMedix Product Offered
Table 144. Helix BioMedix Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 145. Helix BioMedix Main Business
Table 146. Helix BioMedix Latest Developments
Table 147. Helix BioMedix Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 148. MGB Biopharma Limited Product Offered
Table 149. MGB Biopharma Limited Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 150. MGB Biopharma Limited Main Business
Table 151. MGB Biopharma Limited Latest Developments
Table 152. MGB Biopharma Limited Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 153. Lytix Biopharma Product Offered
Table 154. Lytix Biopharma Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 155. Lytix Biopharma Main Business
Table 156. Lytix Biopharma Latest Developments
Table 157. Lytix Biopharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 158. Oragenics Product Offered
Table 159. Oragenics Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 160. Oragenics Main Business
Table 161. Oragenics Latest Developments
Table 162. Oragenics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 163. Microbiotix. Product Offered
Table 164. Microbiotix. Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 165. Microbiotix. Main Business
Table 166. Microbiotix. Latest Developments
Table 167. Microbiotix. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 168. LegoChem Biosciences Product Offered
Table 169. LegoChem Biosciences Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 170. LegoChem Biosciences Main Business
Table 171. LegoChem Biosciences Latest Developments
Table 172. LegoChem Biosciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 173. NovoBiotic Pharmaceuticals Product Offered
Table 174. NovoBiotic Pharmaceuticals Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 175. NovoBiotic Pharmaceuticals Main Business
Table 176. NovoBiotic Pharmaceuticals Latest Developments
Table 177. NovoBiotic Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 178. Shenwei Pharmaceutical Product Offered
Table 179. Shenwei Pharmaceutical Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 180. Shenwei Pharmaceutical Main Business
Table 181. Shenwei Pharmaceutical Latest Developments
Table 182. Shenwei Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 183. North China Pharmaceutical Product Offered
Table 184. North China Pharmaceutical Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 185. North China Pharmaceutical Main Business
Table 186. North China Pharmaceutical Latest Developments
Table 187. North China Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 188. Taiwan Zhengde Pharmaceutical Product Offered
Table 189. Taiwan Zhengde Pharmaceutical Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 190. Taiwan Zhengde Pharmaceutical Main Business
Table 191. Taiwan Zhengde Pharmaceutical Latest Developments
Table 192. Taiwan Zhengde Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 193. Zhejiang Pharmaceutical Product Offered
Table 194. Zhejiang Pharmaceutical Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 195. Zhejiang Pharmaceutical Main Business
Table 196. Zhejiang Pharmaceutical Latest Developments
Table 197. Zhejiang Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 198. Sealife Pharma Product Offered
Table 199. Sealife Pharma Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 200. Sealife Pharma Main Business
Table 201. Sealife Pharma Latest Developments
Table 202. Sealife Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 203. Zhejiang Haizheng Pharmaceutical Product Offered
Table 204. Zhejiang Haizheng Pharmaceutical Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 205. Zhejiang Haizheng Pharmaceutical Main Business
Table 206. Zhejiang Haizheng Pharmaceutical Latest Developments
Table 207. Zhejiang Haizheng Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Vancomycin
Figure 2. Vancomycin Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Vancomycin Consumption Growth Rate 2015-2025 (KG)
Figure 5. Global Vancomycin Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Daptomycin
Figure 7. Product Picture of Linezolid
Figure 8. Product Picture of Quinupristin
Figure 9. Product Picture of Ampicillin
Figure 10. Product Picture of Chloramphenicol
Figure 11. Product Picture of Others
Figure 12. Global Vancomycin Consumption Market Share by Type (2015-2020)
Figure 13. Global Vancomycin Value Market Share by Type (2015-2020)
Figure 14. Vancomycin Consumed in Sepsis
Figure 15. Global Vancomycin Market: Sepsis (2015-2020) (KG)
Figure 16. Global Vancomycin Market: Sepsis (2015-2020) ($ Millions)
Figure 17. Vancomycin Consumed in Lung Infection
Figure 18. Global Vancomycin Market: Lung Infection (2015-2020) (KG)
Figure 19. Global Vancomycin Market: Lung Infection (2015-2020) ($ Millions)
Figure 20. Vancomycin Consumed in Skin Soft Tissue Infection
Figure 21. Global Vancomycin Market: Skin Soft Tissue Infection (2015-2020) (KG)
Figure 22. Global Vancomycin Market: Skin Soft Tissue Infection (2015-2020) ($ Millions)
Figure 23. Vancomycin Consumed in Colitis & Intestinal Inflammation
Figure 24. Global Vancomycin Market: Colitis & Intestinal Inflammation (2015-2020) (KG)
Figure 25. Global Vancomycin Market: Colitis & Intestinal Inflammation (2015-2020) ($ Millions)
Figure 26. Vancomycin Consumed in To Prevent Infection
Figure 27. Global Vancomycin Market: To Prevent Infection (2015-2020) (KG)
Figure 28. Global Vancomycin Market: To Prevent Infection (2015-2020) ($ Millions)
Figure 29. Global Vancomycin Consumption Market Share by Application (2015-2020)
Figure 30. Global Vancomycin Value Market Share by Application (2015-2020)
Figure 31. Global Vancomycin Sales Market Share by Company in 2017
Figure 32. Global Vancomycin Sales Market Share by Company in 2019
Figure 33. Global Vancomycin Revenue Market Share by Company in 2017
Figure 34. Global Vancomycin Revenue Market Share by Company in 2019
Figure 35. Global Vancomycin Sale Price by Company in 2019
Figure 36. Global Vancomycin Consumption Market Share by Regions 2015-2020
Figure 37. Global Vancomycin Value Market Share by Regions 2015-2020
Figure 38. Americas Vancomycin Consumption 2015-2020 (KG)
Figure 39. Americas Vancomycin Value 2015-2020 ($ Millions)
Figure 40. APAC Vancomycin Consumption 2015-2020 (KG)
Figure 41. APAC Vancomycin Value 2015-2020 ($ Millions)
Figure 42. Europe Vancomycin Consumption 2015-2020 (KG)
Figure 43. Europe Vancomycin Value 2015-2020 ($ Millions)
Figure 44. Middle East & Africa Vancomycin Consumption 2015-2020 (KG)
Figure 45. Middle East & Africa Vancomycin Value 2015-2020 ($ Millions)
Figure 46. Americas Vancomycin Consumption Market Share by Countries in 2019
Figure 47. Americas Vancomycin Value Market Share by Countries in 2019
Figure 48. Americas Vancomycin Consumption Market Share by Type in 2019
Figure 49. Americas Vancomycin Consumption Market Share by Application in 2019
Figure 50. United States Vancomycin Consumption Growth 2015-2020 (KG)
Figure 51. United States Vancomycin Value Growth 2015-2020 ($ Millions)
Figure 52. Canada Vancomycin Consumption Growth 2015-2020 (KG)
Figure 53. Canada Vancomycin Value Growth 2015-2020 ($ Millions)
Figure 54. Mexico Vancomycin Consumption Growth 2015-2020 (KG)
Figure 55. Mexico Vancomycin Value Growth 2015-2020 ($ Millions)
Figure 56. APAC Vancomycin Consumption Market Share by Countries in 2019
Figure 57. APAC Vancomycin Value Market Share by Regions in 2019
Figure 58. APAC Vancomycin Consumption Market Share by Type in 2019
Figure 59. APAC Vancomycin Consumption Market Share by Application in 2019
Figure 60. China Vancomycin Consumption Growth 2015-2020 (KG)
Figure 61. China Vancomycin Value Growth 2015-2020 ($ Millions)
Figure 62. Japan Vancomycin Consumption Growth 2015-2020 (KG)
Figure 63. Japan Vancomycin Value Growth 2015-2020 ($ Millions)
Figure 64. Korea Vancomycin Consumption Growth 2015-2020 (KG)
Figure 65. Korea Vancomycin Value Growth 2015-2020 ($ Millions)
Figure 66. Southeast Asia Vancomycin Consumption Growth 2015-2020 (KG)
Figure 67. Southeast Asia Vancomycin Value Growth 2015-2020 ($ Millions)
Figure 68. India Vancomycin Consumption Growth 2015-2020 (KG)
Figure 69. India Vancomycin Value Growth 2015-2020 ($ Millions)
Figure 70. Australia Vancomycin Consumption Growth 2015-2020 (KG)
Figure 71. Australia Vancomycin Value Growth 2015-2020 ($ Millions)
Figure 72. Europe Vancomycin Consumption Market Share by Countries in 2019
Figure 73. Europe Vancomycin Value Market Share by Countries in 2019
Figure 74. Europe Vancomycin Consumption Market Share by Type in 2019
Figure 75. Europe Vancomycin Consumption Market Share by Application in 2019
Figure 76. Germany Vancomycin Consumption Growth 2015-2020

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs